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Long term serum bile acid concentrations in 51 dogs after complete extrahepatic congenital 1 
portosystemic shunt ligation  2 
Objectives: to report the long term bile acid stimulation test results for dogs that have undergone 3 
complete suture ligation of a single congenital extrahepatic portosystemic shunt (EHCPSS)  4 
Methods: data were collected from the hospital records of all dogs that had undergone a complete 5 
suture ligation of an EHCPSS (in one or two procedures). Owners were invited to return to the referral 6 
centre or their local veterinarian. A control population of dogs diagnosed with idiopathic epilepsy 7 
undergoing bile acid stimulation tests were used for comparison. 8 
Results: Fifty-one study dogs were recruited. Mean ± SD follow up time was 62 ± 27.4 months. 48 9 
dogs had no evidence of multiple acquired shunts (MAS) and a significant reduction in the pre and 10 
post-prandial serum bile acid (SBA) concentrations at long-term follow-up compared with pre-11 
operatively, (p=<0.01 and p=<0.01 respectively). At long term follow-up in 64.7% and 86.3% of these 12 
dogs pre- and post-prandial SBAs were above the laboratory’s reference range. Pre- and post- prandial 13 
SBAs were statistically significantly greater for dogs that had undergone a full ligation (with no 14 
evidence of MAS) at all time points compared to the control dogs (p<0.001 for all comparisons).  15 
Clinical significance: SBAs do not normalise in the majority of dogs surgically corrected for their 16 
EHCPSS, remaining mildly increased. The results suggest that in dogs treated with complete suture 17 
ligation mild increases in SBAs are not clinically relevant if present in combination with no physical 18 
examination abnormalities, a normal body condition score and no relapse in clinical signs. 19 
Introduction 20 
A congenital portosystemic shunt (CPSS) is an abnormal vascular communication that diverts blood 21 
away from the portal circulation supplying the liver into the systemic circulation.  The CPSS may be 22 
intra (IHCPSS) or extra hepatic (EHCPSS) and results in liver hypoplasia and hepatic insufficiency. 23 
Clinical signs commonly include poor body condition score and signs of hepatic encephalopathy (HE) 24 
(Centre et al. 1990). CPSS are associated with a variety of hepatic histopathological abnormalities, 25 
indicative of portal hypoperfusion, including biliary and arterial hyperplasia, portal vein hypoplasia 26 
and fibrosis (Cullen et al. 2006). Surgery to attenuate the shunting vessel, thus re-directing hepatic 27 
portal blood flow to the liver is the recommended treatment in most animals (Greenhalgh et al. 2014). 28 
The liver has a great capacity for regeneration via hyperplasia. Increased liver volume, suggestive of 29 
liver regeneration, post-surgery has been confirmed in a small number of dogs with IHCPSS and 30 
EHCPSS using contrast CT and MRI imaging (Kummeling et al. 2010, Stieger et al. 2007). Further 31 
studies have supported the concept that liver regeneration and angiogenesis are important in the 32 
hepatic response to CPSS attenuation (Tivers et al. 2015, Tivers et al. 2014, Tivers et al. 2014). 33 
A variety of surgical techniques exist to achieve acute or gradual CPSS attenuation at surgery 34 
including the use of suture ligation, cellophane band, ameroid constrictor or intravascular coils. 35 
Currently there is no convincing evidence to recommend one treatment over another (Tivers et al. 36 
2012). Residual shunting after the use of a gradual attenuation device is to be expected within the first 37 
few months after surgery, although this should resolve as vessel closure progresses. If attenuation is 38 
incomplete after the use of a gradual occlusion technique then clinical signs can persist. Similarly, if 39 
only a partial ligation has been performed then in some instances clinical signs can persist due to 40 
continued flow through the CPSS. Recurrence of clinical signs can occur with any attenuation method 41 
(gradual occlusion, partial or complete ligation) and can be due to the development of multiple 42 
acquired shunts (MAS) or persistent shunting through an incompletely attenuated shunt. The 43 
incidence of MAS as a complication in the published literature varies depending on the study 44 
population and/or technique used. However, the development of MAS seems to be uncommon,, with 45 
3/29 dogs developing MAS after a partial suture ligation in one study (Burton et al. 2001) and at least 46 
2/15 partial ligations and 1/13 and ameroid ring dogs developed them in another study (Winkler et al. 47 
2003). A further study into ameroid rings found 5/112 died or were euthanized due to MAS and 48 
another study found 3/16 to have MAS following cellophane band placement (Falls et al. 2013, 49 
Landon et al. 2008). In dogs with complete shunt suture ligation and no MAS, the long term clinical 50 
outcome is considered excellent ( Bostwick et al. 1995, Hottinger et al. 1995, Hunt et al. 1999, 51 
Kummeling et al. 2004, Lawrence et al. 1992, Smith et al. 1995), but there is very limited information 52 
on whether this excellent clinical outcome is associated with a long term return to normal biochemical 53 
and liver function (bile acid stimulation test) parameters.  54 
Serum bile acids (SBAs) are commonly used as a diagnostic test for CPSS as well as to monitor 55 
response to surgery, due to the practical ease of performing the test and its high specificity and 56 
sensitivity (Winkler et al. 2014, Ruland et al. 2010). To the authors’ knowledge there are no studies 57 
reporting long term (>18 months post-operatively) SBAs in the veterinary literature for a large group 58 
of dogs after complete shunt ligation. (Hunt et al. 1999; Lawrence et al. 1992). Hunt (1999) reported 59 
follow up at a median of 13.5 months (range 2 weeks to over 6 years) after partial or complete shunt 60 
ligation using a silk ligature, with 36 dogs having biochemistry and either a SBA sample or ammonia 61 
tolerance test (ATT) at the time of follow up. Twenty two per cent (8/36) of these were found to have 62 
abnormal ATT or post prandial SBA and seven of these dogs experienced long term problems related 63 
to persistent shunting, with 10 dogs in total experiencing relapse of clinical signs. All but one of these 64 
dogs did not undergo complete shunt ligation at surgery or imaging to investigate if they were still 65 
shunting at the time of follow up. Therefore it is unknown if the relapse in clinical signs was due to 66 
persistent shunting, the development of MAS or re-cannulisation of the originally ligated shunting 67 
vessel, all of which could have accounted for the increased ATT or SBA. A further study reported 68 
SBA values in 20 dogs at a mean time of 18.6 months (range 2.5-60) post partial ligation (9 dogs) and 69 
complete ligation (11 dogs) of a CPSS. None of these dogs had normal pre-prandial SBA values at 70 
follow-up and only four had normal post-prandial SBAs (Lawrence et al. 1992).  71 
There are reports that indicate improved biochemical and SBA parameters for dogs undergoing 72 
complete shunt ligation at various short-term time points (<1yr), (Burton et al.  2001, Lee et al.  2006). 73 
However there is a lack of long term evidence on whether or not these improvements eventually 74 
normalise, stay the same or even deteriorate, and how this is related to long term clinical outcome.  75 
The main aim of this study therefore was to investigate the long term (>18 months) biochemistry and 76 
bile acid stimulation test results for dogs that had undergone complete suture ligation of a single 77 
congenital extrahepatic portosystemic shunt (EHCPSS). Our null hypothesis was that there would be 78 
no difference in biochemistry and bile acid stimulation test results between dogs that had undergone 79 
complete suture ligation of a single congenital extrahepatic portosystemic shunt (EHCPSS) and 80 
control dogs free of liver disease.  We hypothesised that these results would be normal at this length 81 
of time post-operatively for completely attenuated EHCPSS, without evidence of MAS, due to blood 82 
flow through the shunt being completely occluded and the substantial regenerative capacity of the 83 
liver following surgical correction. Additionally, we aimed to assess the long term physical 84 
examination, body condition score and abdominal ultrasound findings for these dogs to accurately 85 
document their clinical outcome following complete shunt ligation. 86 
 87 
 Materials and Methods 88 
Institutional ethical approval was obtained for the study. Medical records were reviewed for all dogs 89 
that had undergone ligation of a single EHCPSS between January 2000-February 2012. During the 90 
study period at the authors’ institution, complete attenuation with polypropylene (Prolene)a was 91 
performed on all dogs with CPSS if tolerated based on subjective and objective parameters (including 92 
measurement of intraoperative portal pressures, a portovenogram and subjective assessment of 93 
intestinal and pancreatic colour). In dogs that could only tolerate partial shunt ligation at the initial 94 
surgery, the shunt was partially attenuated as much as was deemed appropriate based on the above 95 
parameters using a polypropylene ligature. A repeat surgery was recommended for all dogs, 96 
regardless of clinical response, approximately three months later with the aim of achieving complete 97 
shunt ligation in a second procedure.  Those dogs that did not return for a second surgery were 98 
excluded from the study.  99 
Data collected included signalment, body condition score (BCS), surgery date, anatomical description 100 
of the CPSS (at the time of first surgery for those that went on to have two surgeries) and whether a 101 
complete or partial ligation was achieved in one or two surgical procedures. Each dog’s history was 102 
reviewed and serum bile acids, complete blood count and serum biochemistry from pre- operatively 103 
(at the time of first surgery) and at short term follow up (three months post-operatively from when a 104 
complete attenuation had been achieved) performed at the referral centre were recorded.   105 
Long term (>18 month) follow up data was collected by initially contacting referring veterinary 106 
surgeons to ascertain if the animal was still alive and to obtain up to date client information and 107 
clinical histories. For those alive, owners were contacted by telephone, letter or email and invited to 108 
participate in the study. 109 
Owners were instructed not to feed animals after 10pm the night prior to the appointment. The same 110 
veterinary surgeon took a current history, including diet, medications and health problems since the 111 
last visit, and performed a physical examination and BCS,. A blood sample was taken for pre-prandial 112 
serum bile acids (SBA) and biochemistry. Dogs were then fed and a blood sample for post-prandial 113 
SBA was taken two hours later. In the latter half of the study an abdominal ultrasound was performed 114 
by one of three board certified radiologists. For owners unable to return to our hospital, biochemistry 115 
and bile acid stimulation tests were offered via the referring practice. As part of a related but separate 116 
study, health-related quality of life questionnaires (HRQoL) were also completed by owners (X et al. 117 
Submitted).  118 
Blood samples were sent to Idexx Laboratories for serum bile acid concentration and biochemistry 119 
analysis. The laboratory’s reference ranges are 0.1-5.0µmol/L and 0.1-10.0µmol/L for pre- and post- 120 
prandial samples respectively. Albumin, alanine transferase (ALT) and alkaline phosphate (ALP) 121 
were analysed from the biochemical results. The laboratory’s reference ranges for these are albumin 122 
25-40 g/l, ALT 5-60 U/L and ALP <=130 U/L. 123 
A control population of “normal” dogs undergoing bile acid stimulation tests and taken from a 124 
previous unrelated study performed at the authors’ institution were used for comparison. The control 125 
samples were obtained as part of the diagnostic investigation for idiopathic epilepsy in accordance 126 
with tier 2 of the International veterinary epilepsy task force consensus (De Risio et al. 2015).   127 
Statistical analysis was performed using a commercially available software package (SPSS IBM 128 
Statistics version 20). Categorical data were reported as percentages and compared with Chi-square or 129 
Fisher’s exact tests. Continuous data were assessed for normality using the Shapiro-Wilk Test and 130 
histograms. Median and 25th-75th percentiles were reported for skewed data and mean ± standard 131 
deviation were reported for normally distributed data.  Normally distributed continuous data were 132 
analysed using an independent samples t-test and skewed data were analysed with a Mann-Whitney U 133 
test for independent samples or Wilcoxon signed rank test for related-samples. Significance was set at 134 
p <0.05.  135 
 136 
Results 137 
One hundred and forty five dogs met the inclusion criteria. Of these 94 (66.2%) were still alive at a 138 
mean ± SD follow up time of 177±75 months. Sixteen dogs (11.3%) had died of an unrelated cause at 139 
a mean time of 194 months post-operatively (SD 71). Two (1.4%) had died of causes related to CPSS, 140 
13 and 201 months post-operatively. Six (4.2%) dogs died of an unknown cause at a mean time of 212 141 
months post-operatively, (SD 124). Twenty five (17.6%) dogs were lost to follow up at a mean time 142 
of 263 months post-operatively (SD 75).  143 
Fifty-one dogs participated in the study with three of these having their follow up blood work 144 
performed by their local veterinary practice. The mean ± SD follow up time for these cases was 62 ± 145 
27.4 months from time of complete shunt ligation.  146 
At first surgery, 49% (n=25) of dogs had a full attenuation, and 51% (n=26) had a partial attenuation. 147 
Of the 27 dogs that had a second surgical attenuation, 26 tolerated a full attenuation, and one dog had 148 
developed MAS but had no further shunting through the original CPSS as seen via portovenography.  149 
A variety of breeds were represented with Miniature Schnauzers (15.4%) and cross breeds (13.5%) 150 
being the most common, (table 1). Sex and neutering status are presented in table 2. The median age 151 
at first surgery was 11.9 months (5.8-19.5). 152 
 153 
Physical examination 154 
None of the dogs examined (n=48), had physical examination findings potentially associated with a 155 
CPSS. Twelve dogs had abnormalities including periodontal disease (n=3), ocular discharge (n=2), 156 
lipoma (n=2), and one each of cyst on neck, bilateral luxating patella, pyoderma, brachycephalic 157 
obstructive airway syndrome and grade II/VI heart murmur. The median body condition score was 158 
5/10 (range 4-6/10). Pre-operative body condition score was only available for three dogs and 159 
therefore no comparison was made.  No owners reported a relapse in clinical signs since surgery. 160 
 161 
Complete attenuation dogs, n=48 162 
Bile acid stimulation test results 163 
The median pre-operative pre- and post-prandial SBA were 99.5 umol/L (62.3-124.8) and 245 164 
umol/L, (147.7-351.2) respectively (results available for 45 dogs).  165 
At short term follow up (mean 12 months, SD 15), they were a median of 7.0 umol/L (1.28-19.65) and 166 
21.6 umol/L (14.9-47) respectively, (results available for 22 dogs).  167 
At long term follow up (mean ± SD 158 ± 832.7 months) they were a median of 14.5 umol/L (1.52-168 
29.5) and 38.9 umol/L (17.1-52.5) respectively, (n=48 dogs).  169 
Pre-operatively, 98% of pre and 100% of post-prandial bile acids were above the laboratory reference 170 
range. At short term follow up 82.4% pre- and 98% of post- were above the reference range. At long 171 
term follow up these numbers were 64.7% and 86.3% for pre and post-prandial respectively.  172 
There was a significant reduction in the pre and post-prandial serum bile acid concentrations at both 173 
short (p=<0.01 and p=<0.01 respectively) and long term follow up,  (p=<0.01 and p=<0.01 174 
respectively, figure 1 and 2), compared to the pre-operative values. There was no significant 175 
difference in pre- or post- prandial serum bile acid concentrations between short and long term follow 176 
up (p=0.09 and p=0.06 respectively, figure 1 and 2).  177 
 178 
CBC and biochemistry results 179 
At long term follow up, two dogs were hypoalbuminaemic (15.8 and 27.9 g/l) and seven dogs had 180 
increased ALT at a median of 179.3 U/l. No other abnormalities were detected.  181 
There was a significant difference in the PCV between pre-surgical and short term values, increasing 182 
from a mean of 40.4% (range 38.4-50.6%) pre-operatively to 48.2% (45.7-50.3%) at short term, 183 
(p=0.016). There was insufficient data available to assess PCV at long term follow up. There was a 184 
significant decrease in ALP values between pre-surgical and 3 month post-surgical samples (p=0.004) 185 
and between pre-surgical to long term (p=<0.001), but no difference between short and long term 186 
follow up (p=0.45). There was a significant decrease in ALT values between pre-surgical and 3 month 187 
post-surgical samples (p=0.002) and between pre-surgical and long term follow up samples 188 
(p<0.001). However the ALT did increase significantly between 3 month post-surgical and long term 189 
follow up samples (p=0.04). 190 
There was a significant increase in urea, creatinine and albumin values between pre-surgical and short 191 
term samples (p=<0.001 for all) and for all values between pre-operatively and long term (p=<0.001 192 
for all). There was no significant difference in urea or creatinine values between 3 month post-193 
surgical and long term follow up samples (p=0.45 and p=0.91 respectively), but there was a 194 
significant increase in albumin values from 3 month post-surgical to long term follow up samples 195 
(p=0.017). 196 
 197 
Abdominal ultrasound results 198 
Overall 27 dogs underwent abdominal ultrasound at median follow up of 1406 days (range 598-2917), 199 
25 of which were in the complete attenuation group. These 25 dogs had no evidence of persistent 200 
shunting or MAS. Two dogs had evidence of urolithiasis and one of these dogs had a subjectively 201 
small liver.   202 
 203 
Four of 48 dogs had a post-prandial bile acid at long term follow up > 100 umol/L. Of these four 204 
dogs, three had an abdominal ultrasound performed; in one dog no evidence of liver abnormalities, 205 
MAS or persistent shunting was seen but some cystoliths were present. A second dog had situs 206 
inversus and a full abdominal ultrasound could not be performed due to lack of visualisation, however 207 
a subjectively small liver and cystoliths were seen (as described above). A third case had some 208 
turbulence associated with the shunt ligation site, as had been visualised on a previous post-operative 209 
ultrasound, however this dog had undergone an exploratory laparotomy and portovenogram where no 210 
evidence of persistent shunting or MAS were seen. The final case was not able to come back to our 211 
referral centre for an abdominal ultrasound due to owner restrictions.  212 
 213 
At short term follow up, excluding the two cases described above where an abdominal ultrasound was 214 
not or could not be performed, the pre-prandial 95th percentile was 49.2 umol/L and post-prandial 90.6 215 
umol/L. At long term follow up these values were 93.9 umol/L and 119 umol/L respectively.  216 
 217 
Multiple acquired shunt dogs, n=3 218 
Three dogs were diagnosed with multiple acquired shunts (MAS). One dog was diagnosed at the time 219 
of second surgery, where the previous macroscopic shunt had closed despite being partially attenuated 220 
with a polypropylene ligature. The remaining two dogs were found to have MAS on abdominal 221 
ultrasound when re-examined for this study, following full shunt attenuation. This population 222 
consisted of two Cocker Spaniels one male castrated and one female spayed (age 4.8 and 9.8 years 223 
respectively), and one male castrated Bichon Frise, age 3.6 years.  224 
Two dogs had a pre-operative pre-prandial SBA value available (125.4 and 165 umol/L). All dogs had 225 
a pre-operative post-prandial sample (90, 307.3 and 338.9 umol/L). At short term follow up (n=3), 226 
pre-prandial SBAs were 1.4, 10.7 and 17.3 umol/L and post-prandial SBAs were 23.4, 92 and 133 227 
umol/L. At long term follow up, (mean 124 months, SD 47.8), the pre-prandial SBAs were 50.6, 228 
102.4 and 199.2 umol/L and post-prandial 98.4, 147.3 and 224.7 umol/L. All dogs had SBAs above 229 
the reference range pre-operatively and at long term follow up.  The number of dogs in this group was 230 
too small to perform statistical comparisons.  231 
On biochemical analysis one dog had increased ALT activity (66.2 U/L). No other abnormalities were 232 
detected. The three dogs with MAS were all receiving a restricted protein diet and one was receiving 233 
lactulose. No owners reported a relapse in clinical signs or other abnormalities and the only 234 
abnormality detected on physical examination was ventral pyoderma in one dog.   235 
 236 
Control dogs (n=36) 237 
Median age of the control dogs was 19 months (range 6-165 months). Breeds are presented in table 3. 238 
The median pre-prandial SBAs for control dogs were 0.9 umol/L (25th-75th percentiles 0.5-1.5) and 239 
post-prandial 3.5 umol/L (25th-75th percentiles 1.8-5.3). Pre- and post- prandial SBAs were 240 
statistically significantly greater for dogs that had undergone a full attenuation with no evidence of 241 
MAS at all time points compared to the control dogs (p<0.001 for all comparisons).  242 
 243 
Discussion 244 
The clinical outcome of all dogs available for long term follow-up following complete CPSS ligation 245 
surgery was excellent based on the body condition score and lack of physical examination 246 
abnormalities. However, our null hypothesis that the SBA of dogs following complete surgical 247 
ligation of a CPSS would have returned to normal at long term follow up was rejected. There was a 248 
statistically significant decrease in pre and post-prandial SBA at long term follow up compared to pre-249 
operatively, but 65% and 83% of pre- and post-prandial SBA respectively were still above the 250 
laboratory reference range at a mean follow up of 62 months. This is an interesting finding and the 251 
reason(s) for it are unclear. Abdominal ultrasound was performed in the latter half of the study (once 252 
extra funding became available to do this) to evaluate dogs for possible development of MAS that 253 
were not causing clinical signs as a reason for increased SBA. Only two dogs (out of 27) were 254 
detected with MAS on abdominal ultrasound at long term follow-up. However the dog with the 255 
greatest post-prandial SBA value (215 umol/L) was unable to return for an abdominal ultrasound, and 256 
the dog with the second greatest value was not able to have a full ultrasound performed due to her 257 
situs inversus. Interestingly this dog did have a subjectively small liver and cystoliths and therefore it 258 
would be reasonable to suspect either development of MAS or persistent shunting. However this dog 259 
had a full suture ligation, making the latter possibility unlikely. The sensitivity and specificity of 260 
abdominal ultrasound for the detection of MAS has not been studied extensively although in one 261 
study 1/6 cases of MAS were detected by AUS compared to 4/5 with computed tomography 262 
angiography (CTA), (Kim et al.  2013). CTA would have been a more sensitive and specific method 263 
of detecting MAS. However it is more expensive and requires sedation. Regardless, the incidence of 264 
MAS detected in this study is comparable with many other studies that report rates of MAS between 265 
10-18% (Burton et al. 2001, Winkler et al. 2003, Landon et al. 2008). Most importantly, the rate of 266 
MAS in this study (3.5%) is simply far too low to be solely responsible for the 56% and 79% 267 
persistently elevated pre- and postprandial SBA at long term follow-up, even if the imaging methods 268 
for detecting MAS are not 100% sensitive. Additional support for MAS not being a major cause of the 269 
increased SBAs in our population of dogs was provided by the three dogs that were known to already 270 
have MAS; none of these dogs with MAS had a post-prandial SBA < 98 umol/L.  Overall, our study 271 
showed that long term, pre-prandial values above 94 umol/L and post-prandial above 119 umol/L give 272 
a 95% chance of being abnormal i.e. further investigation of likely residual shunting is warranted.  273 
 274 
Continued shunting through the original CPSS is another possibility for persistently increased SBA if 275 
the shunt has not been completely attenuated (by a ligature, cellophane band or ameroid constrictor). 276 
However, the dogs in this study had documented complete shunt ligation at surgery eliminating 277 
residual shunting as a cause for elevated SBA seen in this population of dogs.  278 
We therefore conclude that there must be another cause for the long term increased SBAs seen in the 279 
majority of dogs receiving a complete EHCPSS ligation in this study, and assume that subclinical 280 
abnormal liver pathology persists once the CPSS is ligated and normal hepatic portal flow resumes. 281 
Aetiologies for this persistent abnormal liver pathology include concurrent microvascular dysplasia / 282 
primary portal vein hypoplasia (PVH) and/or a failure of the liver to recover normal function after 283 
correction of the abnormal blood flow through the CPSS. PVH has been reported as a separate entity 284 
in dogs and it has also been suggested that it can occur concurrently with a macroscopic shunt (Allen 285 
et al.  1999, Christiansen et al.  2000, Phillips 1996, Schermerhorn et al.  1996, ). Our data suggests 286 
that there is a spectrum of varying degrees of concurrent congenital microvascular dysplasia that 287 
results in a high proportion of dogs with a CPSS failing to have normal SBAs after surgical correction 288 
of the single congenital macroscopic shunt. A similar suggestion was made in a previous study where 289 
the authors suggested that it may be possible for some dogs with EHCPSS to have microscopic 290 
shunting as well as a macroscopic shunt, resulting in failure of SBAs to normalise following 291 
successful surgical ligation (O’Leary et al. 2013). It would be very difficult to provide evidence for 292 
this theory as the histopathological hepatic findings associated with PVH are indistinguishable from 293 
those seen in dogs with a macroscopic CPSS and all of the dogs in our study had an excellent long 294 
term clinical outcome. We therefore conclude that whatever the exact aetiology of the liver pathology 295 
causing persistent, mildly (<50 umol/L) increased SBAs in dogs with complete CPSS ligation but 296 
without MAS (median pre prandial 14.5 and post prandial 39.5 umol/L), it is of minimal clinical 297 
significance with regards to long term outcome and does not require further imaging investigations, 298 
medical therapy or special diet. This is further supported by findings in a concurrent study performed 299 
at our hospital, assessing long term quality of life following surgical attenuation of an EHCPSS or 300 
IHCPSS (X et al. Submitted). Additionally, the 95% confidence intervals calculated in the current 301 
study suggest that dogs with pre-prandial and post-prandial values approximately higher than 94 302 
umol/L and 119 umol/L respectively do warrant further investigation of likely persistent shunting.  303 
Interestingly, people with liver disease can suffer from minimal hepatic encephalopathy (MHE)  et al  304 
2007) and although they do not show obvious signs of hepatic encephalopathy (HE) they do have 305 
significant abnormalities in neurophysiological performance and on psychometric testing which may 306 
be something too subtle for us to detect at this stage in dogs.  307 
We will continue to recommend a repeat SBA stimulation test at short term follow up post-operatively 308 
so that if the bile acids are moderately or markedly increased an abdominal ultrasound examination or 309 
other imaging can be performed to assess for residual shunting or MAS.  However, as there was no 310 
significant difference between the SBA at short term and long term follow up, repeat SBA testing 311 
seems unnecessary in the long term providing the dog remains free of clinical signs. 312 
The main limitation of our study is the small number of dogs with MAS, allowing no statistical 313 
comparison between groups. We suspect that if a greater number of dogs had been included with 314 
MAS, a statistically significant difference would have been found in both pre- and post-prandial bile 315 
acids at long term follow up. However the limited numbers also reflects the low number of dogs that 316 
develop MAS following full ligation with a prolene suture.  317 
Of further note, the few papers in the veterinary literature that do include results of long term follow-318 
up SBAs have either no reference range reported making it hard to make comparisons between papers 319 
on the percentage of dogs with abnormal results, or variable reference ranges from 5.3-9.9 umol/L up 320 
to <40umol/L (Burton et al.  2001, Hunt et al.  1999, Lawrence et al.  1992,  O'Leary et al.  2014, 321 
Winkler et al.  2014).  322 
 323 
Conclusion 324 
SBAs do not normalise in the majority of dogs surgically corrected for their EHCPSS although they 325 
become mildly rather than moderately or severely increased in the vast majority of dogs. Given the 326 
excellent clinical outcome of all dogs in this study, long term mildly increased SBA is not a major 327 
concern if present in combination with no physical examination abnormalities, a normal body 328 





Figure Legends 334 
Figure 1: Pre-prandial serum bile acids for dogs with an extrahepatic congenital portosystemic shunt 335 
(EHCPSS) pre-operatively and at short and long term follow-up after complete shunt ligation. The 336 
horizontal line in the box represents the median. The box represents the interquartile range (25th to 337 
75th percentiles). The whiskers represent 1.5 times the interquartile range. Open circles represent 338 
outliers, stars represent extreme values. The dashed line shows the upper end of the laboratory 339 
reference range (5.0umol/l). 340 
Figure 2: Post-prandial serum bile acids for dogs with an extrahepatic congenital portosystemic shunt 341 
(EHCPSS) pre-operatively and at short and long term follow-up after complete shunt ligation. The 342 
horizontal line in the box represents the median. The box represents the interquartile range (25th to 343 
75th percentiles). The whiskers represent 1.5 times the interquartile range. Open circles represent 344 
outliers, stars represent extreme values. The dashed line shows the upper end of the laboratory 345 
reference range (10.0umol/l). 346 
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